Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology

Harvey W Kaufman, William A Meyer III, Nigel J Clarke, Jeff Radcliff, Christopher M Rank, James Freeman, Marcia Eisenberg, Laura Gillim, William G Morice, David M Briscoe, David S Perlin, Jay G Wohlgemuth
doi: https://doi.org/10.1101/2022.08.22.22279079

Article usage

Article usage: August 2022 to December 2024

AbstractFullPdf
Aug 20227171796
Sep 2022219026
Oct 20222071137
Nov 20226707
Dec 202265517
Jan 2023121110
Feb 202342411
Mar 202342110
Apr 20234219
May 20232117
Jun 20232244
Jul 20231611
Aug 202331108
Sep 20232345
Oct 20231944
Nov 20231993
Dec 20231001
Jan 2024924
Feb 20241705
Mar 202419413
Apr 20241359
May 20241002
Jun 2024151012
Jul 202418316
Aug 20242137
Sep 20242338
Oct 20242052
Nov 202429018
Dec 20241108
Back to top
Posted August 23, 2022.
Download PDF
Data/Code
Email
Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
Harvey W Kaufman, William A Meyer III, Nigel J Clarke, Jeff Radcliff, Christopher M Rank, James Freeman, Marcia Eisenberg, Laura Gillim, William G Morice, David M Briscoe, David S Perlin, Jay G Wohlgemuth
medRxiv 2022.08.22.22279079; doi: https://doi.org/10.1101/2022.08.22.22279079
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area